ENDRA Life Sciences Inc

NASDAQ:NDRA   3:58:19 PM EDT
0.20
+0.02 (+9.94%)
7:55:38 PM EDT: $0.19 0.00 (-2.46%)
Earnings Announcements

ENDRA Life Sciences Reports Third Quarter 2022 Financial Results

Published: 11/14/2022 21:35 GMT
ENDRA Life Sciences Inc (NDRA) - Endra Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update.
Endra Life Sciences Inc - Cash and Cash Equivalents Were $8.0 Million As of September 30, 2022.
Endra Life Sciences Inc - Qtrly Net Loss per Share – Basic and Diluted $ 0.05.
Revenue is expected to be $0.7 Million
Adjusted EPS is expected to be -$0.05

Next Quarter Revenue Guidance is expected to be $0.2 Million
Next Quarter EPS Guidance is expected to be -$0.05

More details on our Analysts Page.